Newborn screening in the United States is a public health program which aims to identify genetic conditions in
babies for which early and timely interventions can lead to the elimination or reduction of death and disability.
All babies born in Oklahoma are sceened for
congenital hypothyroidism,
galactosemia,
phenylketonuria (PKU) and
sickle cell disease.
The filter paper blood test must be done prior to a blood transfusion, within the first week of an infant's life, or
immediately prior to hospital discharge, whichever comes first.
Infants in Oklahoma will soon also be tested for
cystic fibrosis (CF),
congenital adrenal hyperplasia (CAH), and
medium chain acyl-CoA dehydrogenase deficiency (MCAD). Parents who want their newborns
tested for these disorders before the screening begins in Oklahoma, or parents that want their infants screened for
additional conditions, can contact the labs listed below.
Pediatrix Screening: http://www.pediatrixscreening.com
Baylor Newborn Screening: http://www.baylorhealth.com/medicalspecialties/metabolicdisease/default.htm
or call (800) 422-9567
Mayo Laboratories: www.mayoclinic.org/laboratorygenetics-rst/newbornscreening.html
or call (800) 533-1710
